Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Historical Holders from Q1 2021 to Q3 2025

Symbol
SANA on Nasdaq
CUSIP
799566104
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
266M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
164M
Holdings value
$581M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
174
Number of buys
107
Number of sells
-55
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 17.3% $164M 46.1M Robert Nelsen Sep 30, 2025
BlackRock, Inc. 4.9% $19.4M 11M BlackRock, Inc. Mar 31, 2025
VANGUARD GROUP INC 4.81% $18.9M 10.7M The Vanguard Group Dec 31, 2024

Institutional Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 164M $581M +$65.8M $3.55 174
2025 Q2 146M $398M -$12.6M $2.73 153
2025 Q1 149M $251M -$14.5M $1.68 156
2024 Q4 158M $257M -$1.26M $1.63 158
2024 Q3 153M $637M +$15.5M $4.16 154
2024 Q2 148M $809M -$350K $5.46 149
2024 Q1 5.84M $58.4M +$5.99M $10.00 13
2023 Q4 78.2K $330K -$46.9K $4.22 2
2023 Q3 127M $492M -$30.2M $3.87 130
2023 Q2 135M $802M +$25.7M $5.96 119
2023 Q1 130M $427M +$6.8M $3.27 116
2022 Q4 128M $507M +$988K $3.95 116
2022 Q3 127M $765M +$15.3M $6.00 115
2022 Q2 125M $801M +$45.8M $6.43 106
2022 Q1 118M $970M +$27.8M $8.26 105
2021 Q4 110M $1.71B +$21.6M $15.48 97
2021 Q3 110M $2.48B +$266M $22.52 88
2021 Q2 64.1M $1.26B +$105M $19.66 77
2021 Q1 58.3M $1.95B +$1.95B $33.47 75